HIGHLINE WEALTH PARTNERS LLC

Position in MRK — Merck & Co., Inc.

CIK 2042654 SHERMAN OAKS, CA

Position in MRK

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$119,762

+$5,006 QoQ

Shares Held

932

-2.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#3,575

of 3,769 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HIGHLINE WEALTH PARTNERS LLC holds $1,353,065 across 14 Drug Manufacturers - General names. MRK ranks #4 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,635	$415,240
2	LLY	ELI LILLY & Co	180	$215,897
3	AMGN	Amgen Inc	429	$155,349
4	MRK	Merck & Co., Inc. This page	932	$119,762
5	ABBV	AbbVie Inc.	419	$105,437
6	AZN	Astrazeneca PLC	314	$59,540
7	PFE	Pfizer Inc	2,356	$56,732
8	GILD	Gilead Sciences, Inc.	446	$56,347

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$119,762	932	-2.3%	Shares	Sole	2026-07-15
2026-03-31	$114,756	954	+24.2%	Shares	Sole	2026-04-06
2025-12-31	$80,839	768	-92.8%	Shares	Sole	2026-01-15
2025-09-30	$895,784	10,673	+0.7%	Shares	Sole	2025-10-14
2025-06-30	$839,096	10,600	+3.0%	Shares	Sole	2025-07-16
2025-03-31	$923,630	10,290	-0.6%	Shares	Sole	2025-04-17
2024-12-31	$1,029,916	10,353	-0.3%	Shares	Sole	2025-01-10
2024-09-30	$1,178,639	10,379	+1.2%	Shares	Sole	2024-10-25
2024-06-30	$1,270,188	10,260	+1.4%	Shares	Sole	2024-10-28
2024-03-31	$1,335,070	10,118	0.0%	Shares	Sole	2024-10-28
2023-12-31	$1,103,064	10,118	0.0%	Shares	Sole	2024-10-29
2023-09-30	$1,041,648	10,118	+0.2%	Shares	Sole	2024-10-29
2023-06-30	$1,164,746	10,094	0.0%	Shares	Sole	2024-10-29
2023-03-31	$1,073,900	10,094	+0.1%	Shares	Sole	2024-10-29
2022-12-31	$1,119,152	10,087	0.0%	Shares	Sole	2024-10-29
2022-09-30	$868,692	10,087	—	Shares	Sole	2024-10-29
No filing history on record for this holder in this stock.